Thunen Shelley B
SEC insider (Form 3/4/5 filer). CIK 0001297491. Director at AEON Biopharma, Inc. (AEON) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SOLANA BEACH, CA.
Companies Thunen Shelley B has filed insider reports for
- AEON Biopharma, Inc. (AEON): Director
- LENZ Therapeutics, Inc. (LENZ): Director
- RxSight, Inc. (RXST): Officer, See remarks
Thunen Shelley B
CIK: 0001297491
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 17, 2026AEON
AEON Biopharma, Inc.
AwardDirect222.7K shares- - Jun 15, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.1K shares- - Jun 11, 2025LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
13.5K shares- - May 21, 2025AEON
AEON Biopharma, Inc.
AwardDirectRestricted Stock Units
308.6K shares- - Apr 14, 2025RXST
RxSight, Inc.
ExerciseDirect7.8K shares at avg. $4.34$34K - Feb 27, 2025RXST
RxSight, Inc.
AwardDirectStock Option (right to buy)
125K shares- - Oct 1, 2024RXST
RxSight, Inc.
SaleDirect9.5K shares at avg. $48.69$464K - Oct 1, 2024RXST
RxSight, Inc.
SaleDirect278 shares at avg. $49.45$14K - Oct 1, 2024RXST
RxSight, Inc.
SaleDirect5.2K shares at avg. $47.96$249K - Oct 1, 2024RXST
RxSight, Inc.
ExerciseDirect15K shares at avg. $16.00$240K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  AEON AEON Biopharma, Inc. | Award | 222,684 | - | $0 | Direct |
| Jun 15, 2026 |  LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 22,100 | - | - | Direct |
| Jun 11, 2025 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 13,500 | - | - | Direct |
| May 21, 2025 | AEON AEON Biopharma, Inc. | Award Restricted Stock Units | 308,641 | - | - | Direct |
| Apr 14, 2025 |  RXST RxSight, Inc. | Exercise | 7,792 | $4.34 | $33,806 | Direct |
| Feb 27, 2025 | RXST RxSight, Inc. | Award Stock Option (right to buy) | 125,000 | - | - | Direct |
| Oct 1, 2024 | RXST RxSight, Inc. | Sale | 9,521 | $48.69 | $463,560 | Direct |
| Oct 1, 2024 | RXST RxSight, Inc. | Sale | 278 | $49.45 | $13,747 | Direct |
| Oct 1, 2024 | RXST RxSight, Inc. | Sale | 5,201 | $47.96 | $249,422 | Direct |
| Oct 1, 2024 | RXST RxSight, Inc. | Exercise | 15,000 | $16.00 | $240,000 | Direct |
1-10 of 11 transactions